<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7699344\results\search\disease\results.xml">
  <result pre="used in traditional Chinese medicine to treat various types of" exact="cancer" post="and inflammatory diseases. There is significant interest in understanding"/>
  <result pre="such as intestinal inflammation, diarrhea, malaria, and different types of" exact="cancer" post="[5,6]. It has been claimed that the fruit is"/>
  <result pre="combination with radiotherapy [14] or chemotherapeutic drugs [15] to improve" exact="cancer" post="treatment efficacy and enhance immune functions [16]. However, BJOE"/>
  <result pre="BJO has been shown to have clinical prospects as a" exact="cancer" post="treatment option, there have been intensive experimental efforts to"/>
  <result pre="activity of BJO. Accordingly, BJO has been shown to inhibit" exact="leukemia" post="[22], liver [23], and lung [24] cancer cells in"/>
  <result pre="shown to inhibit leukemia [22], liver [23], and lung [24]" exact="cancer" post="cells in vitro. BJO can exhibit anticancer activity by"/>
  <result pre="can exhibit anticancer activity by multiple mechanisms, including by inducing" exact="cancer" post="cell apoptosis [25] and inhibiting the function of enzymes"/>
  <result pre="drug resistance mechanisms [26]. It has been discussed how BJO-induced" exact="cancer" post="cell apoptosis can involve the upregulated expression of caspase"/>
  <result pre="invasiveness and angiogenesis [28,29]. In addition, oleic acid can induce" exact="cancer" post="cell apoptosis and autophagy [30]. Importantly, many quassinoids from"/>
  <result pre="found that the quassinoid bruceine D (BD) induced apoptosis of" exact="osteosarcoma" post="cells along with inhibiting cancer cell proliferation and migration"/>
  <result pre="D (BD) induced apoptosis of osteosarcoma cells along with inhibiting" exact="cancer" post="cell proliferation and migration [31]. These inhibitory activities involved"/>
  <result pre="BD blocking a cell signaling pathway that was implicated in" exact="cancer" post="cell malignancy [36]. In addition, BD has been found"/>
  <result pre="malignancy [36]. In addition, BD has been found to inhibit" exact="hepatocellular carcinoma" post="by inhibiting signaling pathways related to liver carcinogenesis and"/>
  <result pre="Anti-Inflammatory Activity Inflammatory bowel diseases such as Crohnâ€™s disease and" exact="ulcerative colitis" post="can affect the small and large intestines and cause"/>
  <result pre="Activity Inflammatory bowel diseases such as Crohnâ€™s disease and ulcerative" exact="colitis" post="can affect the small and large intestines and cause"/>
  <result pre="such as the colon and rectum in the case of" exact="ulcerative colitis," post="whereas Crohnâ€™s disease mainly causes inflammation of the gastrointestinal"/>
  <result pre="activation [42]. Aberrant NF-ÎºB signaling is also a factor in" exact="cancer" post="initiation [43]. In patients with ulcerative colitis, the NF-ÎºB"/>
  <result pre="also a factor in cancer initiation [43]. In patients with" exact="ulcerative colitis," post="the NF-ÎºB pathway has a heightened activity, which can"/>
  <result pre="levels of anti-inflammatory cytokines [41]. In a mouse model of" exact="ulcerative colitis," post="it was also reported that BJOE exhibited therapeutic activity"/>
  <result pre="including BR, have been observed to inhibit induced inflammation and" exact="arthritis" post="in rat models [48]. The oral administration of oleic"/>
  <result pre="has long been suggested that BJO is useful for treating" exact="diabetes mellitus" post="[50], more recent work has investigated which molecular components"/>
  <result pre="human viruses, such as human immunodeficiency virus (HIV) along with" exact="herpes simplex," post="Semliki forest, and Coxsackie viruses [59,60]. 3. Nanomedicine Delivery"/>
  <result pre="exhibited a more potent in vitro cytotoxicity against a human" exact="cervical cancer" post="cell line than BJOE. Wang et al. reported another"/>
  <result pre="a more potent in vitro cytotoxicity against a human cervical" exact="cancer" post="cell line than BJOE. Wang et al. reported another"/>
  <result pre="that the nanoemulsion formulation enabled greater oral bioavailability. In vitro" exact="cancer" post="cell cytotoxicity testing showed that the nanoemulsions also had"/>
  <result pre="also had an appreciably more potent inhibitory activity against multiple" exact="cancer" post="cell lines than a commercial BJOE sample. The improved"/>
  <result pre="result of the nanoemulsionâ€™s size, which might have increased the" exact="cancer" post="cell contact area. In a cancer mouse model bearing"/>
  <result pre="might have increased the cancer cell contact area. In a" exact="cancer" post="mouse model bearing sarcoma tumors, the intragastric administration of"/>
  <result pre="cancer cell contact area. In a cancer mouse model bearing" exact="sarcoma" post="tumors, the intragastric administration of the nanoemulsions and BJOE"/>
  <result pre="nanoparticles exhibited a significantly greater inhibitory activity against lung and" exact="prostate cancer" post="cell lines in vitro than BJOE, and they also"/>
  <result pre="exhibited a significantly greater inhibitory activity against lung and prostate" exact="cancer" post="cell lines in vitro than BJOE, and they also"/>
  <result pre="cell lines in vitro than BJOE, and they also inhibited" exact="cancer" post="cell invasion. There has also been exploration of cationic"/>
  <result pre="more effective treatment than BJOE in a mouse model of" exact="lung cancer," post="in addition to exhibiting a synergistic activity together with"/>
  <result pre="BJO. Nanoemulsions containing the BR quassinoid were used to treat" exact="ulcerative colitis" post="in mice [68]. The nanoemulsions had a diameter of"/>
  <result pre="Nanoemulsions containing the BR quassinoid were used to treat ulcerative" exact="colitis" post="in mice [68]. The nanoemulsions had a diameter of"/>
  <result pre="to encapsulate BD quassinoid and were orally administered to treat" exact="ulcerative colitis" post="in rats. Different excipients were tested as candidates to"/>
  <result pre="encapsulate BD quassinoid and were orally administered to treat ulcerative" exact="colitis" post="in rats. Different excipients were tested as candidates to"/>
  <result pre="of azathioprine (AZA), which is a medication used to treat" exact="colitis" post="and various other ailments. The BD nanoemulsions also reduced"/>
  <result pre="molecular ligands that bind to receptors that are overexpressed on" exact="cancer" post="cells, and one such system based on targeting abundantly"/>
  <result pre="such system based on targeting abundantly expressed receptors present on" exact="ovarian cancer" post="cell surfaces led to an increased intracellular uptake of"/>
  <result pre="system based on targeting abundantly expressed receptors present on ovarian" exact="cancer" post="cell surfaces led to an increased intracellular uptake of"/>
  <result pre="to an increased intracellular uptake of BJO-loaded liposomes, an enhanced" exact="cancer" post="cell inhibition, and a greater apoptosis [72]. Cui et"/>
  <result pre="performance was also observed in a mouse model with Lewis" exact="lung cancer," post="and the treatment outcomes were judged by tumor weight."/>
  <result pre="et al. also investigated the effects of BJO liposomes on" exact="cancer" post="cells in vitro and reported a greater inhibitory activity"/>
  <result pre="for free BJO. In vitro cell cytotoxicity testing against human" exact="lung cancer" post="cells further demonstrated that NLCs without BJO did not"/>
  <result pre="free BJO. In vitro cell cytotoxicity testing against human lung" exact="cancer" post="cells further demonstrated that NLCs without BJO did not"/>
  <result pre="(Figure 5D). In vitro cell cytotoxicity testing against a human" exact="breast cancer" post="cell line revealed that blank LCNPs had no inhibitory"/>
  <result pre="5D). In vitro cell cytotoxicity testing against a human breast" exact="cancer" post="cell line revealed that blank LCNPs had no inhibitory"/>
  <result pre="nanocarrier. Importantly, the LNCPs also enabled inhibition against previously DOX-resistant" exact="cancer" post="cells. 3.4. Spongosomes There has also been an ongoing"/>
  <result pre="efficiency of around 90% even after 30 days. In vitro" exact="cancer" post="cell testing showed that the spongosomes containing 2 mg/mL"/>
  <result pre="both BJO and BAI also demonstrated a superior inhibition of" exact="cancer" post="cells in vitro as compared to spongosomes containing either"/>
  <result pre="a wide range of medical conditions, including various types of" exact="cancer" post="and anti-inflammatory diseases. There is also a significant opportunity"/>
  <result pre="been shown potentially useful in treating neurodegenerative diseases such as" exact="spinal muscular atrophy" post="[82], in stimulating lipolysis in adipocyte cells that could"/>
  <result pre="lipolysis in adipocyte cells that could be useful for combating" exact="obesity" post="[83], in inhibiting insect pests [84], and in treating"/>
  <result pre="Malaysia20059833001793 8.YanZ.ZhangB.HuangY.QiuH.ChenP.GuoG.F.Involvement of autophagy inhibition in Brucea javanica oil emulsion-induced" exact="colon cancer" post="cell deathOncol. Lett.201591425143110.3892/ol.2015.287525663926 9.VieiraI.J.C.Braz-FilhoR.Quassinoids: Structural diversity, biological activity and"/>
  <result pre="8.YanZ.ZhangB.HuangY.QiuH.ChenP.GuoG.F.Involvement of autophagy inhibition in Brucea javanica oil emulsion-induced colon" exact="cancer" post="cell deathOncol. Lett.201591425143110.3892/ol.2015.287525663926 9.VieiraI.J.C.Braz-FilhoR.Quassinoids: Structural diversity, biological activity and"/>
  <result pre="javanicaFitoterapia2015105667210.1016/j.fitote.2015.06.00426071073 22.ZhangH.YangJ.Y.ZhouF.WangL.H.ZhangW.ShaS.WuC.F.Seed oil of Brucea javanica induces apoptotic death of" exact="acute myeloid leukemia" post="cells via both the death receptors and the mitochondrial-related"/>
  <result pre="22.ZhangH.YangJ.Y.ZhouF.WangL.H.ZhangW.ShaS.WuC.F.Seed oil of Brucea javanica induces apoptotic death of acute" exact="myeloid leukemia" post="cells via both the death receptors and the mitochondrial-related"/>
  <result pre="oil of Brucea javanica induces apoptotic death of acute myeloid" exact="leukemia" post="cells via both the death receptors and the mitochondrial-related"/>
  <result pre="Chinese medicinal herb Brucea javanica suppresses the growth of human" exact="liver cancer" post="and the derived stem-like cells by apoptosisDrug Des. Devel."/>
  <result pre="medicinal herb Brucea javanica suppresses the growth of human liver" exact="cancer" post="and the derived stem-like cells by apoptosisDrug Des. Devel."/>
  <result pre="Ther.20161020032013 24.ChenC.WangB.Brucea javanica oil emulsion alleviates cachexia induced by Lewis" exact="lung cancer" post="cells in miceJ. Drug Target.20182622223010.1080/1061186X.2017.135400328701059 25.WangF.CaoY.LiuH.-Y.FuZ.-D.HanR.Experimental studies on the"/>
  <result pre="24.ChenC.WangB.Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung" exact="cancer" post="cells in miceJ. Drug Target.20182622223010.1080/1061186X.2017.135400328701059 25.WangF.CaoY.LiuH.-Y.FuZ.-D.HanR.Experimental studies on the"/>
  <result pre="JavanicaChin. Pharmacol. Bull.200117534539 27.LouG.-G.YaoH.-P.XieL.-P.Brucea javanica oil induces apoptosis in T24" exact="bladder cancer" post="cells via upregulation of caspase-3, caspase-9, and inhibition of"/>
  <result pre="Pharmacol. Bull.200117534539 27.LouG.-G.YaoH.-P.XieL.-P.Brucea javanica oil induces apoptosis in T24 bladder" exact="cancer" post="cells via upregulation of caspase-3, caspase-9, and inhibition of"/>
  <result pre="expressionsAm. J. Chin. Med.20103861362410.1142/S0192415X1000809320503476 28.PazoukiS.BatyJ.WallaceH.ColemanC.Utilization of extracellular lipids by HT29/219" exact="cancer" post="cells in cultureLipids19922782783410.1007/BF025358581362791 29.RingbomT.HussU.StenholmÃ….FlockS.SkattebÃ¸lL.PereraP.BohlinL.COX-2 inhibitory effects of naturally occurring"/>
  <result pre="31.WangS.HuH.ZhongB.ShiD.QingX.ChengC.DengX.ZhangZ.ShaoZ.Bruceine D inhibits tumor growth and stem cell-like traits of" exact="osteosarcoma" post="through inhibition of STAT3 signaling pathwayCancer Med.201987345735810.1002/cam4.261231631559 32.LuoC.WangY.WeiC.ChenY.JiZ.The anti-migration"/>
  <result pre="anti-migration and anti-invasion effects of bruceine D in human triple-negative" exact="breast cancer" post="MDA-MB-231 cellsExp. Ther. Med.20201927327910.3892/etm.2019.818731853299 33.LauS.T.LinZ.-X.LiaoY.ZhaoM.ChengC.H.LeungP.S.Brucein D induces apoptosis in"/>
  <result pre="and anti-invasion effects of bruceine D in human triple-negative breast" exact="cancer" post="MDA-MB-231 cellsExp. Ther. Med.20201927327910.3892/etm.2019.818731853299 33.LauS.T.LinZ.-X.LiaoY.ZhaoM.ChengC.H.LeungP.S.Brucein D induces apoptosis in"/>
  <result pre="kinaseCancer Lett.2009281425210.1016/j.canlet.2009.02.01719286308 34.XieJ.H.LaiZ.Q.ZhengX.H.XianY.F.LiQ.IpS.P.XieY.L.ChenJ.N.SuZ.R.LinZ.X.Apoptosis induced by bruceine D in human non-small-cell" exact="lung cancer" post="cells involves mitochondrial ROS-mediated death signalingInt. J. Mol. Med.2019442015202610.3892/ijmm.2019.436331638181"/>
  <result pre="Lett.2009281425210.1016/j.canlet.2009.02.01719286308 34.XieJ.H.LaiZ.Q.ZhengX.H.XianY.F.LiQ.IpS.P.XieY.L.ChenJ.N.SuZ.R.LinZ.X.Apoptosis induced by bruceine D in human non-small-cell lung" exact="cancer" post="cells involves mitochondrial ROS-mediated death signalingInt. J. Mol. Med.2019442015202610.3892/ijmm.2019.436331638181"/>
  <result pre="mitochondrial ROS-mediated death signalingInt. J. Mol. Med.2019442015202610.3892/ijmm.2019.436331638181 35.ChengZ.YuanX.QuY.LiX.WuG.LiC.ZuX.YangN.KeX.ZhouJ.Bruceine D inhibits" exact="hepatocellular carcinoma" post="growth by targeting Î²-catenin/jagged1 pathwaysCancer Lett.201740319520510.1016/j.canlet.2017.06.01428645563 36.GronerB.von MansteinV.Jak Stat"/>
  <result pre="in castration-resistant prostate cancerTheranostics20211195897310.7150/thno.51478 38.FiaschettiG.GrotzerM.ShalabyT.CastellettiD.ArcaroA.Quassinoids: From traditional drugs to new" exact="cancer" post="therapeuticsCurr. Med. Chem.20111831632810.2174/09298671179483920521143123 39.YuX.-Q.ShangX.-Y.HuangX.-X.YaoG.-D.SongS.-J.Brusatol: A potential anti-tumor quassinoid from"/>
  <result pre="oil emulsion by suppressing NF-ÎºB activation on dextran sulfate sodium-induced" exact="ulcerative colitis" post="in miceJ. Ethnopharmacol.201719838939810.1016/j.jep.2017.01.04228119098 46.LiQ.YangL.FanL.LiangC.WangQ.WenH.DaiJ.LiX.ZhangY.Activity of Brucea javanica oil emulsion"/>
  <result pre="emulsion by suppressing NF-ÎºB activation on dextran sulfate sodium-induced ulcerative" exact="colitis" post="in miceJ. Ethnopharmacol.201719838939810.1016/j.jep.2017.01.04228119098 46.LiQ.YangL.FanL.LiangC.WangQ.WenH.DaiJ.LiX.ZhangY.Activity of Brucea javanica oil emulsion"/>
  <result pre="J. Pharm. Sci.20181327928810.1016/j.ajps.2017.12.00532104401 47.ZhouJ.WangT.DouY.HuangY.QuC.GaoJ.HuangZ.XieY.HuangP.LinZ.Brusatol ameliorates 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental" exact="colitis" post="in rats: Involvement of NF-ÎºB pathway and NLRP3 inflammasomeInt."/>
  <result pre="delivery system and its therapeutic effect against dextran sodium sulfate-induced" exact="ulcerative colitis" post="in miceDrug Deliv.2017241667167910.1080/10717544.2017.138452129078713 69.DouY.-X.ZhouJ.-T.WangT.-T.HuangY.-F.ChenV.P.XieY.-L.LinZ.-X.GaoJ.-S.SuZ.-R.ZengH.-F.Self-nanoemulsifying drug delivery system of bruceine"/>
  <result pre="system and its therapeutic effect against dextran sodium sulfate-induced ulcerative" exact="colitis" post="in miceDrug Deliv.2017241667167910.1080/10717544.2017.138452129078713 69.DouY.-X.ZhouJ.-T.WangT.-T.HuangY.-F.ChenV.P.XieY.-L.LinZ.-X.GaoJ.-S.SuZ.-R.ZengH.-F.Self-nanoemulsifying drug delivery system of bruceine"/>
  <result pre="oil liposomes for ovarian cancerBMC Cancer20161683110.1186/s12885-016-2870-427793127 73.YueY.YangY.ShiL.WangZ.Suppression of human hepatocellular" exact="cancer" post="cell proliferation by Brucea javanica oil-loaded liposomes via induction"/>
  <result pre="for Brucea javanica oil deliveryColloids Surf. B Biointerfaces201715331031910.1016/j.colsurfb.2017.02.03128285062 82.BaekJ.JeongH.HamY.JoY.H.ChoiM.KangM.SonB.ChoiS.RyuH.W.KimJ.Improvement of" exact="spinal muscular atrophy" post="via correction of the SMN2 splicing defect by Brucea"/>
  <result pre="BD-suspension group; (F) Colon lengths of rats in an experimental" exact="colitis" post="model with the following test groups: Intact: no treatment;"/>
  <result pre="as free and NLC-encapsulated BJO on the viability of human" exact="lung cancer" post="cells after 48 h of incubation. Reproduced with permission"/>
  <result pre="free and NLC-encapsulated BJO on the viability of human lung" exact="cancer" post="cells after 48 h of incubation. Reproduced with permission"/>
  <result pre="circulation time. -BJO nanoemulsions had a greater treatment performance against" exact="cancer" post="cells in vitro and mouse tumors in vivo than"/>
  <result pre="than BJOE. -BJO liposomes had a greater treatment performance against" exact="cancer" post="cells in vitro and mouse tumors in vivo than"/>
  <result pre="than BJOE. Nanostructured Lipid Carriers In vitro drug release and" exact="cancer" post="cell inhibition -Loaded BJO with stable encapsulation in ~180-nm"/>
  <result pre="had a greater inhibitory potency than free BJO and induced" exact="cancer" post="cell apoptosis. Spongosomes In vitro drug release and cancer"/>
  <result pre="induced cancer cell apoptosis. Spongosomes In vitro drug release and" exact="cancer" post="cell inhibition --Loaded BJO with stable encapsulation in 60-"/>
 </snippets>
</snippetsTree>
